Trametinib in Patients With Advanced Neurofibromatosis Type 1 (NF1)-Mutant Non-small Cell Lung Cancer
Clinical trial NCT03232892 · TERMINATED
Trial details
- NCT number
- NCT03232892
- Sponsor
- University of California, San Francisco
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-13
- Primary completion
- 2019-09-11
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.